Insider · CIK 0001704021
Friend John E. II
Reports to the SEC for 2 companies · SYDNEY, NSW
Transactions
6
Companies
2
Filings
5
CIK
0001704021
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-01-08 | KZIAKAZIA THERAPEUTICS LTD · Employee Stock Option (right to buy)A Award | — |
| 2026-01-08 | KZIAKAZIA THERAPEUTICS LTD · Restricted Share UnitsA Award | — |
| 2021-03-04 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2020-07-01 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2018-10-12 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2017-04-17 | CLRBCellectar Biosciences, Inc.A Award | — |
Recent filings
- 4Friend John E. II0001213900-26-076430SEC(opens sec.gov)
- 4Friend John E. II0001104659-21-032851SEC(opens sec.gov)
- 4Friend John E. II0001104659-20-080841SEC(opens sec.gov)
- 4Friend John E. II0001144204-18-053876SEC(opens sec.gov)
- 4Cellectar Biosciences, Inc.0001144204-17-020952SEC(opens sec.gov)
Companies
Address
THREE INTERNATIONAL TOWERS, LEVEL 24 300 BARANGAROO AVENUE
SYDNEY, NSW, 2000